Fundamental Data for BSX

BOSTON SCI(NYSE:BSX)

Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company''s products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery.

# Employees: 24800

Address: One Boston Scientific Place,Natick,MA,USA

Phone: 508-650-8000

Fax: 508-650-8923

Website: www.bostonscientific.com

Email: Investor_Relations@bsci.com

Sector: Medical

Industry: MED PRODUCTS

Executive Officers

Pete M. Nicholas (Chmn.; Founder; Dir.)

James R. Tobin (Presi.; C.E.O.; Dir.)

Donald Baim M.D. (Sr. V.P. Chief Med. & Scientific Off.)

Paul Donovan (Sr. V.P.; Corp. Communications)

Paul W. Sandman (Exec. V.P.; Genl. Counsel.; Sec.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 1/27/2010

Mean EPS (Next Qtr): $0.13

Mean EPS (Year): $0.50

Mean Estimate(Long Term): $11.46

P/E Ratio(Based on EPS estimate): 16.090

Number of Estimates: 24

Shares Performance

Period	BSX	Compare to S&P
YTD	4.52 %	-13.49 %
4 Weeks	-7.54 %	-8.54 %
12 Weeks	-29.28 %	-33.33 %

Shares Information

Analyst Coverage: Y

Avg Volume: 22357954

Shares Outstanding: 1507M

Market Cap: $12.20B

52 Week High: $11.75

52 Week Low: $5.48

P/E Ratio: 14.190

PEG Ratio: 1.400

Split: On 11/6/2003 BSX split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: -40.00 %

EPS Growth in Last Year: -25.00 %

Sales Growth in Last Quarter: -2.36 %

Sales Growth in Last Quarter: 2.38 %

Financials

Qtr Book Value: $0.92

Cash Flow/Share: $2.69

Change in Payout Ratio: 0.000

Price/Sales: 1.500